Japan's Eisai said on Monday the country's health ministry had approved its Alzheimer treatment Leqembi, co-developed with US-based Biogen.
The development comes after a health...
A Japanese health ministry panel on Monday recommended approval of the Alzheimer's disease treatment Leqembi, following standard approval for the drug granted by U.S....
CHICAGO: An experimental Alzheimer's disease drug developed by Acumen Pharmaceuticals (ABOS.O) targeting a novel form of the toxic protein beta amyloid in the brain passed...
PARIS: Scientists have used flickering LED lights to shrink, in mouse brains, the beta amyloid plaques associated with Alzheimer's Disease in humans, they reported...
PARIS: Microscopic particles, possibly from air pollution, have been found in human brain tissue, according to a new study which flagged an Alzheimer's risk.